Search Results - "Holck, M"

Arsenic in seafood is associated with increased thyroid-stimulating hormone (TSH) in healthy volunteers – A randomized controlled trial by Molin, M., Ulven, S.M., Dahl, L., Lundebye, A.-K., Holck, M., Alexander, J., Meltzer, H.M., Ydersbond, T.A.

“…•Organic arsenic from seafood increased plasma thyroid-stimulating hormone (TSH).•The increase in TSH was dose dependently associated with plasma…”
Get full text

Urinary excretion of arsenicals following daily intake of various seafoods during a two weeks intervention by Molin, M., Ulven, S.M., Dahl, L., Goessler, W., Fliegel, D., Holck, M., Sloth, J.J., Oshaug, A., Alexander, J., Meltzer, H.M., Ydersbond, T.A.

“…•Blue mussels intake for 15days resulted in concentrations of urinary methylarsonate (MA) of possible toxicological concern.•Intake of different seafood for…”
Get full text

Major and minor arsenic compounds accounting for the total urinary excretion of arsenic following intake of blue mussels (Mytilus edulis): A controlled human study by Molin, M., Ydersbond, T.A., Ulven, S.M., Holck, M., Dahl, L., Sloth, J.J., Fliegel, D., Goessler, W., Alexander, J., Meltzer, H.M.

“…► Bioconversion of arsenicals from blue mussels was studied in this controlled trial. ► Up to 17 different urinary arsenicals were identified. ► The minor As…”
Get full text

Humans seem to produce arsenobetaine and dimethylarsinate after a bolus dose of seafood by Molin, M., Ulven, S.M., Dahl, L., Telle-Hansen, V.H., Holck, M., Skjegstad, G., Ledsaak, O., Sloth, J.J., Goessler, W., Oshaug, A., Alexander, J., Fliegel, D., Ydersbond, T.A., Meltzer, H.M.

“…Seafood is the predominant food source of several organoarsenic compounds. Some seafood species, like crustaceans and seaweed, also contain inorganic arsenic…”
Get full text

Replacing dietary saturated fat with polyunsaturated fat reduces total cholesterol and ldl cholesterol in healthy subjects with moderate hypercholesterolaemia – A randomized controlled trial by Ulven, S.M, Leder, L, Elind, E, Ottestad, I, Christensen, J.J, Telle-Hansen, V.H, Skjetne, A, Torvik, K, Raael, E, Sheikh, N.A, Holck, M, Thyholt, K, Byfuglien, M.G, Granlund, L, Andersen, L.F, Holven, K.B

Get full text

1ISG-011 Development of a predictive model for estimating future drug expenses by Holck, M Vasehus, Fredslund, CKok

“…BackgroundDrug expenses are increasing. Especially novel drugs affect these expenses significantly and existing budgeting forecasts have hitherto not contained…”
Get full text

Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens by Holck, M I, Marks, B H

“…Adenosine and adenosine 5'-monophosphate (AMP) augment contractile responses to norepinephrine (NE) in isolated guinea-pig vas deferens. Dipyridamole slightly…”
Get more information

Differential interactions of clonidine and methoxamine with the postsynaptic alpha-adrenoceptor of rabbit main pulmonary artery by Holck, M I, Jones, C H, Haeusler, G

“…We investigated the dependence upon extracellular Ca2+ of contractile responses of the isolated rabbit main pulmonary artery to the alpha-adrenoceptor…”
Get more information

Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs by Holck, M, Fischli, W, Hefti, F, Gerold, M

“…Cilazapril is a new angiotensin-converting-enzyme inhibitor. In conscious renal-hypertensive dogs, cilazapril (2 X 10 mg/kg/day p.o.) caused a long-lasting…”
Get more information

An angiotensin II antagonist with strongly prolonged action by Holck, M, Bossé, R, Fischli, W, Gerold, H, Escher, E

“…A highly hydrophobic analogue of angiotensin II (AT), [Sar1,(2',3',4',5',6'-Br5)Phe8]AT exhibited strong and persistent specific antagonism against AT, both in…”
Get more information

Effects of chronic myocardial infarction on responsiveness to isoprenaline and the state of myocardial beta adrenoceptors in rats by Clozel, J P, Holck, M, Osterrieder, W, Burkard, W, Da Prada, M D

“…Responsiveness to catecholamines and alterations in myocardial beta adrenoceptors were determined in rats with chronic myocardial infarction. Myocardial…”
Get more information

OC-0759 Shared Decision Making with breast cancer patients - does it work? The randomized DBCG RT SDM trial by Rauff Søndergaard, S., Bechmann, T., Vrou Offersen, B., WM Nielsen, A., Holck Nielsen, M., Møller, M., L. Berry, L., Zachariaee, R., Dahl Steffensen, K.

Get full text

Inhibition of myocardial Ca2+ channels by three dihydropyridines with different structural features: potential‐dependent blockade by Ro 18–3981 by Holck, Mark, Osterrieder, Wolfgang

“…1 Inhibition of myocardial Ca2+ channels was investigated for three dihydropyridines with different structural features: Ro 18–3981, darodipine (PY 108‐068)…”
Get full text

o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel by Kozlowski, R, Ehrhard, P, Fischli, W, Osterrieder, W, Holck, M

“…The binding characteristics and pharmacological properties of o-isothiocyanate dihydropyridine [oNCS-DHP;…”
Get more information

Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline by Hoick, Mark, Osterrieder, Wolfgang

“…1 Cibenzoline, a class 1 (local anaesthetic‐type) antiarrhythmic drug, was investigated for possible effects upon the myocardial Ca2+ inward current. 2 In…”
Get full text

An angiotensin with prolonged action and blood pressure--lowering properties by Bossé, R, Gerold, M, Fischli, W, Holck, M, Escher, E

“…[Sar1,Phe(Br5)8] angiotensin II (Br5Ang II) is a specific, quasi-irreversible antagonist of angiotensin II (Ang II) in vitro. In vivo, this compound is a very…”
Get more information

Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats by Hefti, F, Gerold, M, Holck, M

“…Daily oral administration of tiapamil (2 X 50-2 X 150 mg/kg, for 13 weeks) to spontaneously hypertensive rats (SHR) resulted in a dose-dependent inhibition of…”
Get more information

PD-0740 Danish Breast Cancer Group Skagen Trial 1: A report on annual trial participation by Bech Jellesmark Thorsen, L., Mjaaland, I., Hjelstuen, M., Hugger Jakobsen, E., Berg, M., Lörincz, T., Jensen, I., Kasti, U., Hasler, M., Holck Nielsen, M., Laugaard Lorentzen, E., Aziz-Jowad Al-Rawi, S., Bruun Nielsen, M.M., Krause, M., Linge, A., Kamby, C., Boye, K., Svitzer Yates, E., Vrou Offersen, B.

Get full text

An opioid agonist with preference for kappa-opioid receptors: (-)-N-cyclopropylmethylmorphinan-6-one by Schmidhammer, H, Trenker, E, Burkard, W P, Eggstein-Aeppli, L, Hefti, F, Holck, M I

“…N-Cyclopropylmethyl- and N-cyclobutylmethylmorphinan-6-one (3 and 4, respectively) were prepared from N-methylmorphinan-6-one. The pharmacological studies…”
Get more information

Does [3H]nifedipine label the calcium channel in rabbit myocardium? by Holck, M, Thorens, S, Haeusler, G

“…The ionic and drug specificities of the [3H]nifedipine binding site in rabbit cardiac homogenates were investigated. Divalent cations inhibited specific…”
Get more information